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This issue of The Journal of Thoracic and Cardiovascular Surgery includes a
contribution from the All India Institute of Medical Sciences summarizing a
large experience with total anomalous pulmonary venous connection
TAPVC) that tests a protocol for selective ligation of the vertical vein. 1 After
eaning from cardiopulmonary bypass, the patients underwent test occlusion of the
ertical vein, and if the pulmonary artery pressure increased to systemic or supra-
ystemic levels, the vertical vein was not ligated. The goal was to limit hemody-
amic decompensation in the early postoperative period and therefore improve
urvival. Several important observations are reported. With vertical vein ligation
oth pulmonary artery and left atrial pressures increased, whereas with restoration
f vertical vein patency, in addition to a reduction in pulmonary artery pressure
nd left atrial pressure, mean arterial pressure increased and acidosis resolved.
his suggests a real impact on cardiac output. During pulmonary hypertensive
vents, which were frequent in this series (40% of patients), left-to-right
hunting was observed in the vertical vein and interpreted by the authors as
eneficial. After repair, a patent vertical vein is a connection between the pulmonary
enous atrium and the systemic venous system; it functions like an atrial septal
efect. The authors also intentionally left an additional atrial septal communication
n patients with obstructed TAPVC. The atrial septal defect was left to permit
ight-to-left shunting during pulmonary hypertensive crises.
An intentional atrial septal communication is commonly created for impaired
ight-sided heart function, and the benefits are easy to understand; systemic output
s maintained, albeit at the expense of some systemic desaturation. This concept is
idely applied to patients with a variety of diagnoses, such as tetralogy of Fallot,
ulmonary atresia with intact septum, and Ebstein’s anomaly. Nevertheless, despite
he authors’ careful observations, it is difficult to see how vertical vein patency
ould be of benefit to patients with TAPVC, who are known to have small
oncompliant left-sided chambers that result in elevated filling pressures. How
ould cardiac output be improved by removing preload from the left side? Fur-
hermore, a pulmonary hypertensive crisis results from constriction of pulmonary
rteriolar smooth muscle. The result is, among other things, a preload starved left
entricle with critical reduction in cardiac output. How would a left-to-right shunt
t the atrial level, which exacerbates preload starvation of the left ventricle, be of
ny benefit?
Revisiting some observations made during the early years of cardiology and
ardiac intervention may provide some insight. A situation somewhat, but admit-
edly not perfectly, analogous to the physiology observed early after repaired
APVC is acquired mitral stenosis. In 1916 Lutembacher2 described the impact of
n atrial septal defect on acquired mitral stenosis. At least initially there was the
uggestion that the atrial septal communication limited the impact of mitral stenosis,
erhaps by trading mild elevation of right atrial pressure and pulmonary overcir-
ulation for acute, extreme elevation of left atrial pressure. Over time, individuals
ith mitral stenosis are unquestionably negatively impacted by an atrial septal
efect, which increases the left-to-right shunt and predisposes the patient to atrial
brillation and right ventricular failure. In 1949 Bland and Sweet 3 described the
reation of an atrial level shunt in patients with critical mitral stenosis by anasto-
osing the azygous vein to a pulmonary vein. The goal was to improve the
unctional status of patients with critical rheumatic mitral stenosis, permitting the
spill-over” or pop-off of the congested pulmonary veins into the “less tense and
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Lore capacious systemic venous circulation.”4 The authors
ypothesized that, with impaired left ventricular filling, a
oint is reached where further elevation of left atrial pres-
ure does not result in increased preload to the left ventricle.
he patient is symptomatic as a result of the greatly in-
reased left atrial pressure, and the systemic venous system
an be used to accommodate this volume. The result is a
ecrease in left atrial pressure without a decrease in left-
ided heart output, albeit at the expense of increased right
trial pressure and increased pulmonary blood flow. Bland
nd Sweet’s experiment resulted in symptomatic improve-
ent, but the experience was small and future efforts were
irected at the mitral valve itself and heralded the beginning
f cardiac surgery. The observations of Chowdury and
olleagues,1 Lutembacher,2 Bland,4 and Cope and col-
eagues5 suggest that the systemic venous system and pul-
onary vasculature can accommodate the excess volume
nd limit the impact of excessive left atrial pressure. Nev-
rtheless, any improvement must be short-lived. Eventually,
ith continued shunting, the capacity of the systemic ve-
ous system and the pulmonary vasculature will be over-
helmed, right atrial pressures will increase, left atrial
ressures will return to preintervention levels, and right-
ided heart failure will develop with the added stresses of an
ncreased pulmonary to systemic flow ratio. In essence, it is
imilar to taking the strain off a failing dam by pumping the
ater from the reservoir back upstream; eventually, the
ater will return, testing the dam’s limits once more.
The authors’ observations that acute vertical vein liga-
ion results in greatly elevated left atrial pressure and that
eft ventricular function and cardiac output are negatively
mpacted suggests that for a period of time the small, poorly
ompliant left ventricle of the patient with TAPVC is easily
verwhelmed. Indeed, it is routine to see elevated left atrial
ressure and pulmonary artery pressure combined with sys-
emic hypotension and evidence of decreased cardiac output
fter weaning from cardiopulmonary bypass in patients with
APVC. The postoperative course targets management of
hese issues, and occasionally extracorporeal membrane ox-
genation support is necessary while the pulmonary vascu-
ar bed recovers and left ventricular compliance improves.
he time course of these adjustments is variable, but com-
only the patient with TAPVC with obstruction will have
cceptable hemodynamics, albeit sedated, paralyzed, and
entilated, shortly after arrival in the intensive care unit.
Is it possible that the authors have identified a feedback
oop whereby acute elevation of left atrial pressure results in
xcessive pulmonary arteriolar constriction with an out-of-
roportion pulmonary hypertensive response that further
xacerbates the low cardiac output state caused by a poorly
ompliant left ventricle? Would patients benefit from a
ore gradual ligation of the vertical vein so that acute
136 The Journal of Thoracic and Cardiovascular Surgery ● Malevation of the left atrial pressure is avoided, albeit at the
xpense of some period of pulmonary overcirculation and
levated right-sided filling pressure? Unfortunately, the cur-
ent study design cannot answer that question. To properly
est the hypothesis that “vertical vein ligation results in
nferior outcome,” a prospective randomized trial of ligation
ersus nonligation would be necessary; otherwise, the au-
hors might be responding to short-lived changes that do not
ave an impact on survival or to uncontrolled factors, such
s age, that are stronger predictors of outcome. The call for
randomized prospective study is the last refuge for those
ho cannot accept the findings of a study that conflict with
heir understanding of pathophysiology; furthermore, the
arity and spectrum of TAPVC would make such a trial
ifficult. Nevertheless, there are problems with adopting the
uthors’ recommendations. The patent vertical vein resulted
n right-sided heart failure in approximately half (11/23) of
he survivors. This is a high complication rate for an un-
roven therapy. The two groups differed significantly with
espect to age. Patients in the ligated vertical vein group
ere older and had a higher mortality (29.1%). The in-
reased mortality in these older patients was more likely the
esult of the development of pulmonary hypertension rather
han the use of vertical vein ligation. Indeed, even patients
ith obstructed TAPVC appeared to be older than those
ommonly encountered in North America, and the small
umber of patients (2/58) with infracardiac TAPVC sug-
ests significant presurgical attrition in this group. Finally, it
s difficult to reconcile the use of both an atrial septal defect
nd a persistent vertical vein, which are physiologically
quivalent. How can we expect two atrial level communi-
ations, the persistent vertical vein and the atrial septal
efect, to shunt in different directions in response to the
ame hemodynamic event? At present the best outcomes for
atients with TAPVC are achieved with early diagnosis and
imely, accurate repair with minimal manipulation of the
ulmonary veins, vertical vein ligation, and careful postop-
rative management targeting maintenance of cardiac
utput.
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